- What's New?
Discover the latest information about VeraLIght
- Sign Up
Join our e-mail list to get the latest updates on SCOUT DS™ technology
- Subscribe to our RSS Feed
Welcome to VeraLight
VeraLight is a medical device company that was established in October 2004 to focus on a comprehensive approach to non-invasive type 2 diabetes and pre-diabetes screening with the proprietary SCOUT DS™ system. Our mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications. The company develops and acquires intellectual property, products, and services that contribute to this mission.
The SCOUT DS test employs fluorescence spectroscopy to non-invasively measure advanced glycation endproducts (AGEs) in the skin of an individual’s forearm. Skin AGEs are a well-known biomarker of diabetes, an excellent indicator of cumulative hyperglycemic exposure, and have been shown to predict the development of type 2 diabetes.
Caution: Federal law restricts the SCOUT DS system to investigational use only.